Hinen Australia's Grand Christmas Promotion Officially Launches, Buy Your First Hinen System and Get a FREE 1800W Power Station Valued at AUD 1,500
SYDNEY, Nov. 15, 2024 (GLOBE NEWSWIRE) -- As the Christmas bells draw near, Hinen Australia today announced the launch of its highly anticipated Christmas promotion, bringing unprecedented surprises for consumers seeking green energy and smart home solutions. From today until 15th December, 2024, new customers who purchase the Hinen single-phase low-voltage residential storage solution (5kW single-phase hybrid inverter H5000s + 5kW low-voltage battery B5000) will receive a free Hinen 1800W portable power station PS1800, valued at 1500 AUD.
Hinen Australia Christmas Promotion
Why choose Hinen Single-Phase Low-Voltage Residential Storage Solution?
With its outstanding technology and top-tier safety performance, the Hinen single-phase low-voltage residential storage solution has garnered widespread acclaim in the Australian market, with highlights including:
High-efficiency solar energy conversion: The H5000s inverter supports up to 200% over-configuration, with a maximum photovoltaic input of 10kW, maximizing the use of solar energy.
Comprehensive safety protection: The system is equipped with multiple protection mechanisms, such as overcharge, over-discharge, and short-circuit protection, and is fitted with an intelligent gas extinguisher that responds quickly within 15 seconds to ensure battery safety.
Strong environmental adaptability: The system has an IP65 rating for dust and water resistance and can withstand extreme temperatures from -20°C to +60°C, fearless in the face of floods, ice, snow, and high temperatures.
Long-lasting durability: The system offers a 10-year warranty, ensuring long-term stable operation.
Flexible configuration: Supports AC Coupled mode, compatible with any existing solar inverters, enhancing power supply stability; Grid Forming function prevents energy waste during power grid outages.
Silent operation: The fanless design ensures noise levels are ≤25dB, creating a quiet environment.
Rapid response: The EPS conversion time is less than 20 milliseconds, ensuring seamless power transition.
Gift Highlight: 1800W Portable Power Station PS1800
The gift PS1800 also performs exceptionally:
High-performance battery: Uses LiFePO4 batteries with a cycle life of up to 3000 times, supports 1.5-hour fast charging, and has a maximum output power of 1800W.
Multiple Safety Protections: The built-in BMS provides eight layers of safety protection against overtemperature, overcurrent, and overvoltage issues.
Intelligent cooling: Features an internal air cooling system that performs well even under high loads.
Uninterrupted power supply: The switchover time is less than 14 milliseconds, ensuring continuous operation of critical devices.
Multi-mode charging: Supports grid, solar panel, and vehicle charging, suitable for a wide range of applications.
Intelligent monitoring: Real-time monitoring through the Hinen APP, supports constant power mode, capable of driving devices up to 2400W.
Story Continues
How to Participate
For more details on the promotion or to participate in the sale, please: Visit the official website: https://au.hinen.com/pages/christmas-promotion
Send an email to service@hinen.com.au
Call the hotline: 0417 727 039
Hinen Australia cordially invites all consumers interested in green energy solutions to seize this rare opportunity and experience the efficient, safe, and reliable energy storage solutions brought by Hinen. Let's welcome a Christmas filled with light and warmth together!
* Hinen Australia reserves the right to interpret this promotion.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8cbc80b3-affd-4144-8f97-7bf87ea056d3
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
$13.16 Bn Human Growth Hormone (HGH) Market Trends and Forecasts, 2020-2024 & 2025-2030: Strategic R&D Initiatives, Regulatory Approvals, and Collaborations Shaping the Landscape
The Human Growth Hormone market offers significant opportunities driven by the rise in growth hormone deficiencies and aging populations seeking HGH therapy. The demand is boosted by potential anti-aging and wellness benefits, with biosimilars presenting a cost-effective alternative. Key challenges include high costs and ethical issues. Human Growth Hormone (HGH) Market Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "Human Growth Hormone (HGH) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to Human Growth Hormone (HGH) Market was valued at USD 6.21 Billion in 2024, and is expected to reach USD 13.16 Billion by 2030, rising at a CAGR of 13.29% This rapidly evolving sector within the pharmaceutical and biotechnology industry centers on the use of somatotropin - a crucial hormone produced by the pituitary gland - to support growth, development, and metabolic functions. Key growth drivers include the rising prevalence of growth hormone deficiencies (GHD), especially among children, and increased interest in HGH therapy among the aging population to address age-related hormonal decline. In addition to its approved medical applications, HGH is being explored for its potential anti-aging and wellness benefits, further expanding its demand. The market features a wide range of products, including recombinant human growth hormone (rhGH) and biosimilars, with injectable formulations dominating the segment. Strategic R&D initiatives, regulatory approvals, and collaborations among pharmaceutical companies are shaping the market's competitive landscape. However, accessibility issues and high treatment costs remain challenges, alongside ethical concerns about off-label use for enhancement Market Drivers Increasing Prevalence of Growth Hormone Deficiency (GHD)The growing incidence of Growth Hormone Deficiency (GHD) remains a primary catalyst for the Human Growth Hormone (HGH) market globally. GHD, caused by inadequate hormone secretion from the pituitary gland, significantly affects growth, especially in children, and impacts overall health in adults. Current estimates suggest that GHD occurs in 1 out of every 4,000 to 10,000 live births, with a substantial number of adult-onset cases recorded annually. Greater awareness and improved diagnostic tools have enabled earlier detection and intervention, enhancing patient factors include poor nutrition, increased stress, genetic disorders, and medical conditions involving the hypothalamic-pituitary axis. As access to healthcare broadens, more individuals are seeking evaluation and treatment for growth-related disorders, spurring pharmaceutical companies to develop long-acting therapies and improve patient compliance. This growing patient population continues to drive demand for HGH treatment solutions Market Challenges High CostCost remains a significant barrier in the Global Human Growth Hormone (HGH) Market. The complex production process of recombinant human growth hormone (rhGH), involving high-end biotechnological methods and rigorous quality standards, contributes to elevated prices. The long duration of therapy, often lasting several years, further increases the financial burden on patients and healthcare systems. Limited insurance coverage in certain regions and insufficient public health resources exacerbate access issues. As a result, many patients are unable to afford or maintain treatment, especially in lower-income markets. Addressing affordability through cost-effective production and pricing strategies is essential to broaden access to life-enhancing HGH Market Trends BiosimilarsThe growing presence of biosimilars is a transformative trend in the Global Human Growth Hormone (HGH) Market. These are biologic products designed to closely resemble original rhGH therapies in terms of safety, efficacy, and quality, but at a more accessible price point. Biosimilars undergo stringent regulatory scrutiny and clinical testing to ensure comparable performance to reference introduction promotes market competition, helping to reduce treatment costs and improve patient access. As biosimilar adoption expands, particularly in cost-sensitive regions, their role in the market is increasing. Nevertheless, regulatory approval processes, interchangeability protocols, and manufacturing consistency remain key considerations. Overall, biosimilars represent a promising path toward greater affordability and availability of HGH treatments. Key Attributes: Report Attribute Details No. of Pages 185 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $6.21 Billion Forecasted Market Value (USD) by 2030 $13.16 Billion Compound Annual Growth Rate 13.2% Regions Covered Global Report Scope: Key Market Players Novo Nordisk A/S Eli Lilly and Company Pfizer, Inc. Sandoz International GmbH (Novartis AG) Genentech, Inc. (Roche) Merck KGaA Ferring Pharmaceuticals Ipsen Pharma Teva Pharmaceutical Industries, Ltd. Human Growth Hormone (HGH) Market, By Product: Long Acting Others Human Growth Hormone (HGH) Market, By Application: Growth Hormone (GH) Deficiency Turner Syndrome Idiopathic Short Stature Prader-Willi Syndrome Small for Gestational Age Other Human Growth Hormone (HGH) Market, By Distribution Channel: Hospital Pharmacy Retail Pharmacy Online Pharmacy Specialty Pharmacy Human Growth Hormone (HGH) Market, By Region: North America United States Canada Mexico Europe France United Kingdom Italy Germany Spain Asia-Pacific China India Japan Australia South Korea South America Brazil Argentina Colombia Middle East & Africa South Africa Saudi Arabia UAE For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Human Growth Hormone (HGH) Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Australia's Qantas to close low-cost arm Jetstar Asia
(Reuters) -Australian flag carrier Qantas said on Wednesday it will close Jetstar Asia, the group's Singapore-based low-cost unit, in a bid to recycle up to A$500 million ($326.40 million)as part of its fleet renewal plans. Qantas said that 13 Jetstar Asia Airbus A320 aircraft will be progressively redeployed to Australia and New Zealand. Jetstar Asia continues to be negatively affected by rising supplier costs, high fees at airports and rising competition in the region. "This has fundamentally challenged the low-cost airline's ability to deliver returns comparable to the stronger performing core markets in the group," Qantas said. Jetstar Asia is currently expected to post an underlying EBIT loss of A$35 million in the current financial year. The airline will cease operating on July 31 and will continue flights for the next seven weeks. ($1 = 1.5319 Australian dollars) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
NAB worker blocks grandmother's $50,000 transfer after noticing tiny detail
An 84-year-old Australian grandmother has been saved from financial heartbreak after a NAB worker noticed a tiny detail. The woman from the NSW Hunter Valley went into a branch to make a request that "instantly" set off red flags. She wanted her daily withdrawal limit to be increased from $5,000 to $50,000, a 1,000 per cent increase. The woman made the request so that she could authorise a particularly pricey cash transfer. That alone was enough to raise NAB customer adviser Tiffany Bailey's eyebrows. $60 billion reason why you could get locked out of your account Major RBA interest rate call set to give homeowners $250 per month win $400 cash boost available for thousands of Aussies in new energy rebate But another tiny detail sparked much bigger alarm bells for the banker. Bailey noticed the grandmother was holding her phone in her hand while she was making the withdrawal limit request. When she showed her phone to the bank staff, it was revealed she was on a call with someone the whole time. They searched the phone number on the internet, and their investigation revealed it was likely a person had convinced the grandmother she owed them $50,000 and had been pressuring her for days to send them the money. They had even started threatening the woman with dire consequences if she didn't go into a NAB branch and change her details so that she could transfer the cash. She had absolutely no idea she was being scammed. The scammer had coached her on what to say when she went in, which she had written down in a notebook. When the bank staff asked her what was inside the book, she broke down in tears and confessed what was really going on. "They are the biggest low lives on the planet," NAB relief branch manager Vanessa Kruger told 9News. "They prey on people who are vulnerable, try to trick them, it actually makes my blood boil." NAB was able to secure the woman's account and she returned the following week very happy she hadn't become another scam statistic. The grandmother nearly became a victim of what's called a remote access scam. This is when a scammer will call or reach out to an unsuspecting person claiming to be from a trusted organisation like a government entity, a telecommunications provider, or a bank. They will claim that something is wrong with your device or account and you need to download certain programs or software, or grant them access to fix the problem. They might even ask for your personal details, and bank or credit card information. They can be very convincing and already have some of your personal information to sound more legitimate. Once they have access to your device or account, it can open up a can of worms that can lead to your money and your details being compromised. If you receive calls, text messages, or emails from out of the blue or from numbers or names you don't recognise, Scamwatch encourages people to avoid them at all costs. Aussies lost a staggering $15.5 million to remote access scams in 2023. In the first quarter of 2024, there was a 57 per cent increase in average losses compared to the year prior, with victims losing roughly $17,943 in retrieving data Sign in to access your portfolio Error in retrieving data
